The record selling season and raised guidance signal strong momentum into 2027. Monitor Q4 2026 results for member engagement and the pace of new client launches, as well as the February 2027 guidance for 2027.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $34.37entry
- T+1 · 11d ago +1.37%α +1.06% · $34.84
- T+5 · 5d ago +6.43%α +3.14% · $36.58
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Progyny reported Q3 2026 revenue of $341.3M (+8.9% YoY) and adjusted EPS of $0.52, beating the $0.51 consensus. The company raised the midpoint of its full-year 2026 revenue guidance to $1.365B-$1.385B and adjusted EPS to $2.09-$2.13, driven by a record selling season adding 1.3M new covered lives and near-100% retention.
Key Financial Metrics
Key Facts
- Q3 2026 revenue $341.3M, +8.9% YoY, vs consensus $340.8M
- Q3 2026 adjusted EPS $0.52, vs consensus $0.51
- GAAP diluted EPS $0.32, vs $0.15 YoY
- Gross margin 24.5%, up from 23.2% YoY
- Adjusted EBITDA $58.4M, +6.3% YoY; margin 17.1% vs 17.5% YoY
- Record selling season: 1.3M new covered lives, 85+ new clients, near-100% retention
- Full-year 2026 revenue guidance raised to $1.365B-$1.385B (midpoint $1.375B)
- Full-year 2026 adjusted EPS guidance raised to $2.09-$2.13
- Repurchased nearly 3M shares for $82.7M in Q3; $51M remaining under authorization
- 607 clients as of Sep 30, 2026, up from 553 a year ago
Financial Impact
Revenue beat consensus by ~$0.5M; adjusted EPS beat by $0.01; full-year guidance midpoint raised by ~$10M on revenue and ~$0.02 on adjusted EPS
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Fertility benefit services | $223.4M | +10.6% |
| Pharmacy benefit services | $117.9M | +5.8% |
Risk Factors
- Adjusted EBITDA margin declined slightly YoY (17.1% vs 17.5%) due to planned investments
- Heavy share repurchase activity ($231.4M YTD) reduces share count but consumes cash
- Dependence on large client retention; one client with ~300K members not reflected in utilization metrics
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3395762 |
Track record
26 reports on PGNY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Viewing Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers